rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

CapsoVision, Inc.

CV · Nasdaq

Health CareMedical DevicesSetting up

CV stood above a rising 150-day average in 16 of the last 33 weekly readings, and has been out of that trend for the last 1 week. It is 1.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 1
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$42.0M
Insider sales, 12 months
$17K
Officials’ trades on record
0
Institutions holding
50 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 33 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$38.6MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6
Sale orders, 12 months1
Buyers · sellers2 · 1
WhoDidSharesTraded
Eliyahou Et Al Harari10% ownerbought878,735at $5.6918 Sep 2026filed 23 Sep 2026
Eliyahou Et Al Harari10% ownerbought878,734at $5.6918 Sep 2026filed 23 Sep 2026
Ching Hang Shen10% ownerbought878,734at $5.6915 Sep 2026filed 18 Sep 2026
Ching Hang Shen10% ownerbought878,734at $5.6915 Sep 2026filed 23 Sep 2026
Eliyahou Et Al Harari10% ownerbought61,068at $6.7317 Jul 2026filed 21 Jul 2026
Eliyahou Et Al Harari10% ownerbought81,300at $6.098 Jul 2026filed 10 Jul 2026
Eliyahou Et Al Harari10% ownerbought13,850at $7.3526 Jun 2026filed 7 Jul 2026
Joanne Carol ImperialDirectorsold1,200at $7.168 Jun 2026filed 1 Jul 2026
Chen Lung TsaiDirectorbought20at $4.173 Jul 2025filed 6 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders50+3 on the quarter
New · exited9 · 7
Reported value$39.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20261,896,088$14.4M+591,667+45.4%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,058,468$8.0M+32,199+3.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026578,482$4.4M+143,328+32.9%
STATE STREET CORPadded · filed 7 Aug 2026410,241$3.1M+154,200+60.2%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026240,425$1.8M+76,039+46.3%
NORTHERN TRUST CORPadded · filed 13 Aug 2026220,095$1.7M+67,761+44.5%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026103,630$786K+14,998+16.9%
CHARLES SCHWAB INVESTMENT MANAGEMENT INCadded · filed 14 Aug 202679,360$602K+17,983+29.3%
Sixth Street Partners Management Company, L.P.new · filed 14 Aug 202679,360$602K+79,360
Bank of New York Mellon Corpadded · filed 6 Aug 202675,021$569K+25,727+52.2%
30 Sep 2025 – 30 Jun 2026
253749Sep 25Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Eliyahou Et Al Harari Company insider10% owner · last 18 Sep 20264 · 0
Ching Hang Shen Company insider10% owner · last 15 Sep 20262 · 0
David Stanley Shields Company insiderDirector · last 1 Jul 20260 · 0
Chen Lung Tsai Company insiderDirector · last 30 Jun 20261 · 0
Hui Ying Kuo Company insiderDirector · last 30 Jun 20260 · 0
Joanne Carol Imperial Company insiderDirector · last 30 Jun 20260 · 1
Julia S. Gouw Company insiderDirector · last 30 Jun 20260 · 0
Michele Harari Company insiderDirector · last 30 Jun 20260 · 0
Wen-Herng Henry King Company insiderDirector · last 30 Jun 20260 · 0
David Michael Garcia Company insiderSr. VP of Finance · last 1 Jun 20260 · 0
Douglas Patrick Atkinson Company insiderHead of Global Sales · last 1 Jun 20260 · 0
Kang-Huai Wang Company insiderDirector, Officer · last 1 Jun 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202552.9%
Operating profit marginFY 2025 · to 31 Dec 2025-188%
Free cash flow marginFY 2025 · to 31 Dec 2025-169%
Return on capital employedFY 2025 · to 31 Dec 2025-186%
Research spendFY 2025 · to 31 Dec 2025135%
Share count trendFY 2025 · to 25 Mar 20266.3%
Free cash flowFY 2025 · to 31 Dec 2025−$23.0M

Analyst forecasts

No analyst forecasts yet.